These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 17039445

  • 1. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N, Gore TC, Duncan KL, Coyne MJ, Lum MA, Sterner FJ.
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [Abstract] [Full Text] [Related]

  • 2. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC, Lakshmanan N, Duncan KL, Coyne MJ, Lum MA, Sterner FJ.
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY, Larson L, Payne L, Tubbs A, Wasmoen T, Schultz R.
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
    Pardo MC, Bauman JE, Mackowiak M.
    Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M, Namikawa K, Maruo T, Lynch J, Sahara H.
    Vet Rec; 2010 Dec 11; 167(24):931-4. PubMed ID: 21262693
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thoughts on vaccination protocols.
    McLaughlin MA.
    J Am Vet Med Assoc; 2000 Nov 15; 217(10):1458-9. PubMed ID: 11128530
    [No Abstract] [Full Text] [Related]

  • 14. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL, Thompson M, Tate D, Bonderer A, Chen YJ.
    J Am Vet Med Assoc; 1998 Jul 01; 213(1):72-5. PubMed ID: 9656027
    [Abstract] [Full Text] [Related]

  • 15. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA, Bergman JG, Theelen RP, Jaspers R, Helps JM, Horspool LJ, Paul G.
    Vet Rec; 2007 Jan 13; 160(2):41-5. PubMed ID: 17220520
    [Abstract] [Full Text] [Related]

  • 16. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ, Schultz RD.
    Am J Vet Res; 1997 Apr 13; 58(4):360-3. PubMed ID: 9099379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
    Mitchell SA, Zwijnenberg RJ, Huang J, Hodge A, Day MJ.
    Aust Vet J; 2012 Dec 13; 90(12):468-73. PubMed ID: 23186088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.